Publication | Closed Access
MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer
16
Citations
38
References
2016
Year
Breast OncologyMedicinePathologyDocetaxel-based Neoadjuvant ChemotherapyBreast CancerCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentTumor BiologyCancer GrowthMyc Amplification
| Year | Citations | |
|---|---|---|
Page 1
Page 1